uMed

Based in the United Kingdom, uMed is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.

uMed connects patient EMR records from millions of patients across the UK, Australia, and the US with real-time data collected directly from patients at home. This creates real-world, consented patient cohorts for specific diseases, enabling sponsors to access and query these cohorts for additional prospective data collection.